Moderna chief executive Stephane Bancel said he wants to take his company’s mRNA vaccine manufacturing to every continent in the world, Reuters reported.
“We’re talking to a couple more countries, because I would really like on every continent to have mRNA capacity,” Bancel said during a panel at the annual meeting of the World Economic Forum (WEF), in Davos, Switzerland.
Moderna, which has rapidly advanced from a little-known Massachusetts-based clinical stage company to a dominant player in the global vaccine market over the course of the COVID-19 pandemic, is planning overseas expansions of its mRNA vaccine-making capacity.
In August 2021, Moderna signed a memorandum of understanding with the Canadian government to build a “state-of-the-art messenger RNA” vaccine-manufacturing facility. The goal, according to the company, is to make sure Canada can activate the site and secure “direct access to rapid pandemic response capabilities” in the event of a “future pandemic.”…